The integration of digital health into cardiological care is revolutionizing cardiology and transforming patient treatment and management, especially in the wake of the COVID-19 pandemic. Telehealth, a key component of digital health, has emerged as a vital tool for cardiologists, enabling them to overcome traditional barriers to patient access.

For a brief health segment, Dr. Jose Medina-Inojosa, Assistant Professor of Epidemiology Mayo Clinic, discussed the transformative impact that PTZ (Pan-Tilt-Zoom) cameras have in healthcare, particularly in intensive care, telestroke units, and remote collaboration in medical settings.

Assistant Professor of Epidemiology for the Mayo Clinic College of Medicine at Mayo Clinic, Jose Medina-Inojosa MD MSc, breaks down the groundbreaking innovation in hypertension treatment with the introduction of Zilebesiran. Published in the prestigious New England Journal of Medicine, this study has ignited excitement in the medical community, offering new hope for the millions affected by hypertension, the notorious "silent killer.

We tested the hypothesis that BF content measured by air displacement plethysmography (Bod-Pod®) had a stronger association with prevalent hypertension (HTN), diabetes mellitus (DM) and dyslipidemia (DLP) when compared to BMI.

Arrhythmias commonly occur during clinical exercise stress testing (EST), however there are limited data on prognostic significance, particularly differences between individuals with minor versus significant arrhythmia burden. We hypothesized that significant but not minor arrhythmia burden during EST would be predictive of future all-cause mortality.

Mark Cuban's Cost Plus Drugs is making waves in the pharmacy market, gaining more than 1.2 million customers and selling over 1000 generic low-cost drugs at a fraction of the prescription price that Big Pharma puts on the marketplace.